PHRI: Bayer, PHRI and C-SPIN to conduct Phase III trial of rivaroxaban to treat ESUS patients

Bayer HealthCare along with its partner Janssen Research & Development has entered into a collaboration with the Population Health Research Institute (PHRI) and the Canadian Stroke Prevention Intervention Network (C-SPIN) to carry out a Phase III NAVIGATE ESUS study in patients with a recent embolic stroke of undetermined source (ESUS).